Cargando…
Virus replicon particle based Chikungunya virus neutralization assay using Gaussia luciferase as readout
BACKGROUND: Chikungunya virus (CHIKV) has been responsible for large epidemic outbreaks causing fever, headache, rash and severe arthralgia. So far, no specific treatment or vaccine is available. As nucleic acid amplification can only be used during the viremic phase of the disease, serological test...
Autores principales: | Gläsker, Sabine, Lulla, Aleksei, Lulla, Valeria, Couderc, Therese, Drexler, Jan Felix, Liljeström, Peter, Lecuit, Marc, Drosten, Christian, Merits, Andres, Kümmerer, Beate Mareike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3718613/ https://www.ncbi.nlm.nih.gov/pubmed/23855906 http://dx.doi.org/10.1186/1743-422X-10-235 |
Ejemplares similares
-
Inhibitors of Alphavirus Entry and Replication Identified with a Stable Chikungunya Replicon Cell Line and Virus-Based Assays
por: Pohjala, Leena, et al.
Publicado: (2011) -
Infectious RNA vaccine protects mice against chikungunya virus infection
por: Szurgot, Inga, et al.
Publicado: (2020) -
Insertion of EGFP into the replicase gene of Semliki Forest virus results in a novel, genetically stable marker virus
por: Tamberg, Nele, et al.
Publicado: (2007) -
Development of Viral-Vectored Vaccines and Virus Replicon Particle-Based Neutralisation Assay against Mayaro Virus
por: Kim, Young Chan, et al.
Publicado: (2022) -
In Vivo Imaging of Ligand Receptor Binding with Gaussia Luciferase Complementation
por: Luker, Kathryn E., et al.
Publicado: (2011)